These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 682114)
1. Naltrexone, morphine and cocaine interactions in mice and rats. Blumberg H; Ikeda C J Pharmacol Exp Ther; 1978 Aug; 206(2):303-10. PubMed ID: 682114 [No Abstract] [Full Text] [Related]
2. Alteration of ethanol effects by opiate antagonists. Harris RA; Erickson CK Curr Alcohol; 1979; 5():17-28. PubMed ID: 755620 [No Abstract] [Full Text] [Related]
3. The lack of effect of opioid agonists and antagonists on some acute effects of ethanol. Kotlińska J; Langwiński R Pol J Pharmacol Pharm; 1990; 42(2):129-35. PubMed ID: 2274471 [TBL] [Abstract][Full Text] [Related]
4. Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior. Harris RA J Pharmacol Exp Ther; 1980 Jun; 213(3):497-503. PubMed ID: 6110766 [TBL] [Abstract][Full Text] [Related]
5. Toxic interactions of stimulants, narcotics and narcotic antagonists. Leander JD; Lucot JB Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):255-64. PubMed ID: 877411 [TBL] [Abstract][Full Text] [Related]
6. An evaluation of the hot plate technique to study narcotic antagonists. Heilman RD; Gray MI; Chen RP; Hahn EF; Fishman J Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):635-47. PubMed ID: 1265343 [TBL] [Abstract][Full Text] [Related]
7. Sustained release of naltrexone from glyceride implants. Sullivan MF; Kalkwarf DR Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):27-32. PubMed ID: 967232 [TBL] [Abstract][Full Text] [Related]
8. Plasma corticosteroid levels in rats maintained on a long-acting naltrexone delivery system. Misra AL; Pontani RB; Vadlamani NL Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):43-50. PubMed ID: 663407 [TBL] [Abstract][Full Text] [Related]
9. [Effects of the opiate antagonists naloxone and naltrexone on the body temperature of rats]. Iakimova K Eksp Med Morfol; 1987; 26(1):23-7. PubMed ID: 3595494 [No Abstract] [Full Text] [Related]
10. Sustained release of naltrexone from glyceride implants. Sullivan MF; Kalkward DR Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):27-32. PubMed ID: 1234982 [TBL] [Abstract][Full Text] [Related]
11. Development of Chronomers for narcotic antagonists. Capozza RC; Schmitt EE; Sendelbeck LR Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):39-42. PubMed ID: 13306 [TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of perinatal naltrexone exposure: a preliminary investigation. Harry GJ; Rosecrans JA Pharmacol Biochem Behav; 1979; 11 Suppl():19-22. PubMed ID: 550130 [No Abstract] [Full Text] [Related]
13. Naltrexone and the tail flick reflex. Advokat C Pharmacol Biochem Behav; 1981 Nov; 15(5):677-80. PubMed ID: 7312906 [TBL] [Abstract][Full Text] [Related]
14. Influence of chronic prenatal and postnatal administration of naltrexone in locomotor activity induced by morphine in mice. Medina Jiménez M; Luján Estrada M; Rodríguez R Arch Med Res; 1997; 28(1):61-5. PubMed ID: 9078589 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine. Ward SJ; Portoghese PS; Takemori AE J Pharmacol Exp Ther; 1982 Mar; 220(3):494-8. PubMed ID: 6121045 [TBL] [Abstract][Full Text] [Related]
16. Further studies on the alteration of analgesic receptor-antagonist interaction induced by morphine. Tulunay FC; Takemori AE J Pharmacol Exp Ther; 1974 Sep; 190(3):401-7. PubMed ID: 4153360 [No Abstract] [Full Text] [Related]
17. Assays for narcotic antagonist activity in rodents. Pierson AK Adv Biochem Psychopharmacol; 1973; 8(0):245-61. PubMed ID: 4152786 [No Abstract] [Full Text] [Related]
18. Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine. Larson AA; Armstrong MJ Eur J Pharmacol; 1980 Nov; 68(1):25-31. PubMed ID: 6161013 [No Abstract] [Full Text] [Related]
19. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure. France CP; Woods JH J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506 [TBL] [Abstract][Full Text] [Related]
20. DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine. Cheng HY; Laviolette SR; van der Kooy D; Penninger JM Eur J Neurosci; 2004 Jun; 19(11):3033-41. PubMed ID: 15182311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]